Eastern Cooperative Oncology Group

This phase 2 trial is testing four different drug combinations in 373 older adults (age 60+) with previously untreated mantle cell lymphoma, a rare blood cancer. The goal is to see which combination best delays cancer progression. Patients receive either rituximab plus bendamusti…

This study tests whether adding daratumumab to standard treatment (bortezomib and dexamethasone) can improve kidney function better than the usual approach (cyclophosphamide, bortezomib, and dexamethasone) in people newly diagnosed with multiple myeloma who also have kidney failu…

This study looks at adults with slow-growing brain tumors (low-grade gliomas) that are causing symptoms or getting worse. It compares radiation therapy alone versus radiation plus the chemotherapy drug temozolomide. The goal is to see if adding chemo helps people live longer with…